| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |